VeriMom¿Es sodium chitosan caprylamide hydroxypropylsulfonate seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
Related ingredients
Frequently asked questions
- ¿Es sodium chitosan caprylamide hydroxypropylsulfonate seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.
- ¿Es sodium chitosan caprylamide hydroxypropylsulfonate seguro durante la lactancia?
- No evidence of reproductive or lactation toxicity; no data suggesting systemic absorption in adults or transfer into breast milk. No harmonised CLP flags or CIR/SCCS concerns were identified. Therefore default low hazard and negligible exposure for breastfeeding mothers from topical cosmetic use.
- ¿Es sodium chitosan caprylamide hydroxypropylsulfonate seguro para la piel del bebé?
- No infant‑specific reproductive or systemic toxicity data were identified. The ingredient is a high‑molecular‑weight chitosan derivative and likely shows limited skin penetration, but infant skin barrier immaturity and higher surface‑area‑to‑weight justify an exposure score increased by +1 relative to adults. No evidence was found to increase hazard or mechanism scores for infants.
- ¿Cómo puntúa VeriMom a sodium chitosan caprylamide hydroxypropylsulfonate?
- VeriMom puntúa sodium chitosan caprylamide hydroxypropylsulfonate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a sodium chitosan caprylamide hydroxypropylsulfonate en el embarazo?
- Consulta nuestra lista de alternativas seguras a sodium chitosan caprylamide hydroxypropylsulfonate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.